Last edition
News about "Aurolife Pharma"
Aurobindo Pharma receives US Food and Drug Administration (FDA) final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, marking its first Metered-Dose Inhaler (MDI) product and expanding its complex respiratory portfolio.
Aurolife Pharma | 16/09/2026 | By News Bureau
Aurobindo Pharma's Raleigh Plant Receives VAI Classification from US FDA
Aurobindo Pharma’s Raleigh plant receives Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (FDA), closing the inspection and allowing pending inhaler and dosage-form applications to progress.
Aurolife Pharma | 17/08/2026 | By News Bureau | 123
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy